Is ingenpharma.eu Safe? Security Analysis for Ingen Pharma
https://www.ingenpharma.euCheck if ingenpharma.eu is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for ingenpharma.eu
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Ingen Pharma is a Latvian pharmaceutical company specializing in the development, manufacturing, and sales of generic and OTC pharmaceutical products primarily serving Latvia and Lithuania. The company emphasizes quality and affordability, targeting healthcare providers and consumers seeking cost-effective medicines. The website is professionally designed using modern technologies such as Bootstrap and jQuery, with good mobile optimization and clear navigation. However, it lacks some advanced SEO and accessibility features. Security posture is moderate with HTTPS enabled and Google reCAPTCHA implemented, but missing important security headers and cookie consent mechanisms. WHOIS data is fully redacted due to EURid policies, which is common for .eu domains but reduces transparency. Overall, the website is functional and trustworthy but could improve privacy compliance and security best practices.
Detected Technologies
15 urgent findings need attention
3 critical · 12 high
- + 7 more findings in the full report below
Keep ingenpharma.eu under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
8 findings
15/100
GDPR Compliance
5 findings
28/100
NIS2 Compliance
9 findings
2/100
Email Security
5 findings
60/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Ingen Pharma operates in the healthcare sector focusing on generic and OTC pharmaceuticals in the Baltic region. The business model centers on manufacturing and selling affordable medicines with a strong ethical stance. The company appears to be small-sized with no public parent or subsidiary companies. The website content and branding are consistent and professional, supporting a credible market position. No social media or partner domains are linked, indicating a focused but limited digital ecosystem. The lack of phone contact and physical address on the website may limit customer engagement. The company’s use of Google reCAPTCHA suggests attention to bot mitigation but no advanced marketing or analytics tools are detected.
Security Posture Analysis
Comprehensive Security Assessment
The website uses HTTPS and includes Google reCAPTCHA, which are positive security indicators. However, the absence of key security headers such as Content-Security-Policy, X-Frame-Options, and HSTS reduces the overall security posture. No forms are present on the homepage, limiting attack surface, but the lack of cookie consent and privacy policy details indicates incomplete privacy compliance. WHOIS data is fully redacted, which is standard for .eu domains but reduces transparency. No vulnerabilities or exposed sensitive data were detected in the provided content. The security score is moderate, with recommendations to implement security headers and privacy mechanisms to enhance protection and compliance.
Strategic Recommendations
Priority Actions for Security Improvement
Implement comprehensive security headers including Content-Security-Policy, X-Frame-Options, X-Content-Type-Options, and Strict-Transport-Security.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Ingen Pharma
Ingen Pharma is a Latvian based Pharmaceutical company specializing in the development, manufacturing and sales of top selling generic products and branded OTC products in Latvia and Lithuania. They apply the highest standards of service and offer premium quality products at affordable prices. The team consists of experts with extensive experience in the generic pharmaceutical area and a passion for entrepreneurship, conducting business with honesty, integrity, fairness and care.
good
consistent
Technical Stack
moderate
good
basic
basic
Security Assessment
- HTTPS enabled
- Use of Google reCAPTCHA on forms
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with no blocking or WAF challenges
Get this report delivered to your inbox
Receive a summary of the ingenpharma.eu security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Strict-Transport-Security header
HIGHForces HTTPS connections
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing X-Content-Type-Options header
MEDIUMPrevents MIME type sniffing
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
EU business without adequate privacy measures
CRITICALEU businesses are subject to strict GDPR requirements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: transport, health, digital
Need this report as a PDF?
Download the complete ingenpharma.eu security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
No email authentication configured
CRITICALDomain is vulnerable to email spoofing
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 34 days
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
High-Risk Service Exposed: FTP
HIGHPort 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer
Service Exposed: SSH
MEDIUMPort 22 (SSH) is publicly accessible - SSH - Secure but can be brute-forced
Critical Service Exposed: MySQL
CRITICALPort 3306 (MySQL) is publicly accessible - MySQL - Database server
How does ingenpharma.eu compare?
ingenpharma.eu scores below average. Browse similar domains to see how competitors handle security.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the ingenpharma.eu report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Want OffSeq to fix this?
Book a 30-minute remediation call
Our security engineers can resolve the high-severity findings identified in this report — from SSL misconfigurations and missing headers to compliance gaps and infrastructure hardening.
OffSeq provides end-to-end cybersecurity services: penetration testing, vulnerability remediation, compliance consulting, and continuous monitoring. View all services
Scan your own website
Liked the ingenpharma.eu report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about ingenpharma.eu
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published